These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6313408)

  • 1. Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines.
    Sidell N; Altman A; Haussler MR; Seeger RC
    Exp Cell Res; 1983 Oct; 148(1):21-30. PubMed ID: 6313408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procoagulant activity of human neuroblastoma cell lines, in relation to cell growth, differentiation and cytogenetic abnormalities.
    Esumi N; Imashuku S; Tsunamoto K; Todo S; Misawa S; Goto T; Fujisawa Y
    Jpn J Cancer Res; 1989 May; 80(5):438-43. PubMed ID: 2502520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid.
    Pan M; Zhang Y; Wright WC; Liu X; Passaia B; Currier D; Low J; Chapple RH; Steele JA; Connelly JP; Lu M; Lee HM; Loughran AJ; Yang L; Abraham BJ; Pruett-Miller SM; Freeman B; Campbell GE; Dyer MA; Chen T; Stewart E; Koo S; Sheppard H; Easton J; Geeleher P
    bioRxiv; 2024 May; ():. PubMed ID: 38798584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro.
    Sidell N
    J Natl Cancer Inst; 1982 Apr; 68(4):589-96. PubMed ID: 7040765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours.
    Seiboldt T; Zeiser C; Nguyen D; Celikyürekli S; Herter S; Najafi S; Stroh-Dege A; Meulenbroeks C; Mack N; Salem-Altintas R; Westermann F; Schlesner M; Milde T; Kool M; Holland-Letz T; Vogler M; Peterziel H; Witt O; Oehme I
    Br J Cancer; 2024 Sep; 131(4):763-777. PubMed ID: 38942989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying Morphology of a Differentiating Neuroblastoma Cell Line.
    Fang J; Kuwamoto W; Miranda G; Rajagopalan V; Elul T
    MicroPubl Biol; 2024; 2024():. PubMed ID: 38571511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma.
    Abu-Zaid A; Fang J; Jin H; Singh S; Pichavaram P; Wu Q; Tillman H; Janke L; Rosikiewicz W; Xu B; Van De Velde LA; Guo Y; Li Y; Shendy NAM; Delahunty IM; Rankovic Z; Chen T; Chen X; Freeman KW; Hatley ME; Durbin AD; Murray PJ; Murphy AJ; Thomas PG; Davidoff AM; Yang J
    Cell Rep Med; 2024 Mar; 5(3):101468. PubMed ID: 38508144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects.
    Makimoto A; Fujisaki H; Matsumoto K; Takahashi Y; Cho Y; Morikawa Y; Yuza Y; Tajiri T; Iehara T
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial uncoupler and retinoic acid synergistically induce differentiation and inhibit proliferation in neuroblastoma.
    Jiang H; Tiche SJ; He CJ; Jedoui M; Forgo B; Zhao M; He B; Li Y; Li AM; Truong AT; Ho J; Simmermaker C; Yang Y; Zhou MN; Hu Z; Cuthbertson DJ; Svensson KJ; Hazard FK; Shimada H; Chiu B; Ye J
    bioRxiv; 2024 Jan; ():. PubMed ID: 38328117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension.
    Mühlethaler-Mottet A; Uccella S; Marchiori D; La Rosa S; Daraspe J; Balmas Bourloud K; Beck Popovic M; Eugster PJ; Grouzmann E; Abid K
    Front Endocrinol (Lausanne); 2022; 13():1027856. PubMed ID: 36531507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super-enhancer associated core regulatory circuits mediate susceptibility to retinoic acid in neuroblastoma cells.
    Gomez RL; Woods LM; Ramachandran R; Abou Tayoun AN; Philpott A; Ali FR
    Front Cell Dev Biol; 2022; 10():943924. PubMed ID: 36147741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid rewires the adrenergic core regulatory circuitry of childhood neuroblastoma.
    Zimmerman MW; Durbin AD; He S; Oppel F; Shi H; Tao T; Li Z; Berezovskaya A; Liu Y; Zhang J; Young RA; Abraham BJ; Look AT
    Sci Adv; 2021 Oct; 7(43):eabe0834. PubMed ID: 34669465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging.
    Lazic D; Kromp F; Rifatbegovic F; Repiscak P; Kirr M; Mivalt F; Halbritter F; Bernkopf M; Bileck A; Ussowicz M; Ambros IM; Ambros PF; Gerner C; Ladenstein R; Ostalecki C; Taschner-Mandl S
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective on Similarities and Possible Overlaps of Congenital Disease Formation-Exemplified on a Case of Congenital Diaphragmatic Hernia and Neuroblastoma in a Neonate.
    Huo Z; Bilang R; Brantner B; von der Weid N; Holland-Cunz SG; Gros SJ
    Children (Basel); 2021 Feb; 8(2):. PubMed ID: 33671521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of DUSP26: Structure, Regulation and Relevance in Human Disease.
    Thompson EM; Stoker AW
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor.
    Chasse MH; Johnson BK; Boguslawski EA; Sorensen KM; Rosien JE; Kang MH; Reynolds CP; Heo L; Madaj ZB; Beddows I; Foxa GE; Kitchen-Goosen SM; Williams BO; Triche TJ; Grohar PJ
    EMBO Mol Med; 2021 Feb; 13(2):e12640. PubMed ID: 33332735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regorafenib is effective against neuroblastoma in vitro and in vivo and inhibits the RAS/MAPK, PI3K/Akt/mTOR and Fos/Jun pathways.
    Subramonian D; Phanhthilath N; Rinehardt H; Flynn S; Huo Y; Zhang J; Messer K; Mo Q; Huang S; Lesperance J; Zage PE
    Br J Cancer; 2020 Aug; 123(4):568-579. PubMed ID: 32457362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.
    Marayati R; Williams AP; Bownes LV; Quinn CH; Stewart JE; Mroczek-Musulman E; Atigadda VR; Beierle EA
    J Pediatr Surg; 2020 Jun; 55(6):1072-1080. PubMed ID: 32164984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative discovery of treatments for high-risk neuroblastoma.
    Almstedt E; Elgendy R; Hekmati N; Rosén E; Wärn C; Olsen TK; Dyberg C; Doroszko M; Larsson I; Sundström A; Arsenian Henriksson M; Påhlman S; Bexell D; Vanlandewijck M; Kogner P; Jörnsten R; Krona C; Nelander S
    Nat Commun; 2020 Jan; 11(1):71. PubMed ID: 31900415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulator polyinosinic-polycytidylic acid enhances the inhibitory effect of 13-cis-retinoic acid on neuroblastoma through a TLR3-related immunogenic-apoptotic response.
    Chuang HC; Lin HY; Liao PL; Huang CC; Lin LL; Hsu WM; Chuang JH
    Lab Invest; 2020 Apr; 100(4):606-618. PubMed ID: 31857701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.